Aduro BioTech Inc Logo Image

Aduro BioTech Inc

Aduro BioTech Inc Banner Image

Aduro BioTech Inc has reached its limit for report views.

Please check back to see if Aduro BioTech Inc has upgraded their profile page to allow their financial information to be viewed. In the meantime, here are a few annual reports from similar companies.

Most Recent Annual Report

2016 Annual Report, Interactive Annual Report and Form 10K

Aduro BioTech Inc

Aduro BioTech Inc does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



Archived Annual Reports

  • Aduro BioTech Inc

About Aduro BioTech Inc

51-200 Employees
Based in Berkeley, California

Aduro BioTech, Inc., a clinical-stage immuno-oncology company, focuses on the development of technology platforms designed to stimulate robust and durable immune responses against cancer. Its lead product candidate is CRS-207, which is in a Phase IIb clinical trial for the treatment of metastatic pancreatic cancer and unresectable malignant pleural mesothelioma.

Ticker:
ADRO
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol